239 related articles for article (PubMed ID: 15651049)
1. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of recombinant human tissue kallikrein at 2.0 A resolution.
Katz BA; Liu B; Barnes M; Springman EB
Protein Sci; 1998 Apr; 7(4):875-85. PubMed ID: 9568894
[TBL] [Abstract][Full Text] [Related]
3. A structural model for the prostate disease marker, human prostate-specific antigen.
Villoutreix BO; Getzoff ED; Griffin JH
Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of phenylmethanesulfonyl fluoride-treated human chymase at 1.9 A.
McGrath ME; Mirzadegan T; Schmidt BF
Biochemistry; 1997 Nov; 36(47):14318-24. PubMed ID: 9400368
[TBL] [Abstract][Full Text] [Related]
5. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of human tissue kallikrein 4: activity modulation by a specific zinc binding site.
Debela M; Magdolen V; Grimminger V; Sommerhoff C; Messerschmidt A; Huber R; Friedrich R; Bode W; Goettig P
J Mol Biol; 2006 Oct; 362(5):1094-107. PubMed ID: 16950394
[TBL] [Abstract][Full Text] [Related]
7. A novel substrate-binding pocket interaction restricts the specificity of the human NK cell-specific serine protease, Met-ase-1.
Smyth MJ; O'Connor MD; Trapani JA; Kershaw MH; Brinkworth RI
J Immunol; 1996 Jun; 156(11):4174-81. PubMed ID: 8666785
[TBL] [Abstract][Full Text] [Related]
8. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
[TBL] [Abstract][Full Text] [Related]
9. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
[TBL] [Abstract][Full Text] [Related]
10. Structure-function relationship of serine protease-protein inhibitor interaction.
Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
[TBL] [Abstract][Full Text] [Related]
11. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II.
Sabo TM; Farrell DH; Maurer MC
Biochemistry; 2006 Jun; 45(24):7434-45. PubMed ID: 16768439
[TBL] [Abstract][Full Text] [Related]
12. The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity.
Kiss AL; Hornung B; Rádi K; Gengeliczki Z; Sztáray B; Juhász T; Szeltner Z; Harmat V; Polgár L
J Mol Biol; 2007 Apr; 368(2):509-20. PubMed ID: 17350041
[TBL] [Abstract][Full Text] [Related]
13. Trimeric structure of PRL-1 phosphatase reveals an active enzyme conformation and regulation mechanisms.
Jeong DG; Kim SJ; Kim JH; Son JH; Park MR; Lim SM; Yoon TS; Ryu SE
J Mol Biol; 2005 Jan; 345(2):401-13. PubMed ID: 15571731
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of human tissue kallikrein produced in Escherichia coli: biochemical comparison to the enzymatically inactive prokallikrein and methionyl kallikrein.
Lu HS; Hsu YR; Lu LI; Ruff D; Lyons D; Lin FK
Protein Expr Purif; 1996 Sep; 8(2):215-26. PubMed ID: 8812865
[TBL] [Abstract][Full Text] [Related]
15. Human tissue kallikreins: a new enzymatic cascade pathway?
Yousef GM; Diamandis EP
Biol Chem; 2002; 383(7-8):1045-57. PubMed ID: 12437087
[TBL] [Abstract][Full Text] [Related]
16. Classification of serine proteases derived from steric comparisons of their active sites, part II: "Ser, His, Asp arrangements in proteolytic and nonproteolytic proteins".
Barth A; Frost K; Wahab M; Brandt W; Schadler HD; Franke R
Drug Des Discov; 1994 Nov; 12(2):89-111. PubMed ID: 9116171
[TBL] [Abstract][Full Text] [Related]
17. Modeling of prostate specific antigen and human glandular kallikrein structures.
Vihinen M
Biochem Biophys Res Commun; 1994 Nov; 204(3):1251-6. PubMed ID: 7526861
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
Czapinska H; Helland R; Smalås AO; Otlewski J
J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of a novel viral protease with a serine/lysine catalytic dyad mechanism.
Feldman AR; Lee J; Delmas B; Paetzel M
J Mol Biol; 2006 May; 358(5):1378-89. PubMed ID: 16584747
[TBL] [Abstract][Full Text] [Related]
20. The role of the protein core in the inhibitory power of the classic serine protease inhibitor, chymotrypsin inhibitor 2.
Radisky ES; King DS; Kwan G; Koshland DE
Biochemistry; 2003 Jun; 42(21):6484-92. PubMed ID: 12767231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
